Daniel P. O’Day

Daniel P. O’Day

Chairman and Chief Executive OfficeratGilead Sciences· In proxies 2019–2025

Pay in FY2025+20% from the year before · Gilead Sciences stock +32.9% the same year

Daniel P. O’Day was paid $28.4M in FY2025 (Dec), up 20%. Gilead Sciences stock rose 32.9% that year.

Pay$100 in the stock at the end of FY18 → $231
Pay is from the Summary Compensation Table of each Gilead Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Gilead SciencesPublic company · 7 yr
    • Chairman and Chief Executive Officer2019 – Present · 7 yrStock in role +210%
  2. Digital/Technology – Driven InnoPublic company
    • Director? – PresentNo stock prices for these years
  3. Digital/Technology – Driven InnovatioPublic company
    • Director? – PresentNo stock prices for these years
  4. ►NonePublic company
    • Director? – PresentNo stock prices for these years
  5. Flatiron HealthPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?